Showing results (1221-1230 of 1,339) with videos related to
Sort By:
Pageof 134
Blood|December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphomaChristian Grommes, Sarah S Tang, Julia Wolfe, et al.Biorxiv : the Preprint Server for Biology|July 24, 2020
Cold sensitivity of the SARS-CoV-2 spike ectodomainRobert J Edwards, Katayoun Mansouri, Victoria Stalls, et al.The Journal of Clinical Investigation|June 30, 2020
Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's diseaseSouvarish Sarkar, Hai M Nguyen, Emir Malovic, et al.Journal of Medicinal Chemistry|December 22, 1999
Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferaseC Z Ding, R Batorsky, R Bhide, et al.Journal of Medicinal Chemistry|March 5, 2010
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): increasing cellular potency through optimization of a distal heteroaromatic groupBart M J M Suijkerbuijk, Ion Niculescu-Duvaz, Catherine Gaulon, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodiesRory Henderson, Kara Anasti, Kartik Manne, et al.Cell Reports. Medicine|December 27, 2024
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquineGanji Purnachandra Nagaraju, Madhu Sudhana Saddala, Jeremy B Foote, et al.New Microbes and New Infections|September 2, 2025
An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunityIsabel H Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, et al.Journal of Medicinal Chemistry|October 6, 2000
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activityJ T Hunt, C Z Ding, R Batorsky, et al.Bioorganic & Medicinal Chemistry Letters|February 22, 2008
Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinaseGretchen M Schroeder, Xiao-Tao Chen, David K Williams, et al.Pageof 134